These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 8319282)
1. [Screening for Down's syndrome in the 2d trimester of pregnancy: initial results]. Stejskal D Cesk Gynekol; 1993 Feb; 58(1):5-10. PubMed ID: 8319282 [TBL] [Abstract][Full Text] [Related]
2. Second-trimester maternal serum alpha-fetoprotein and human chorionic gonadotrophin screening for Down's syndrome in Hong Kong. Lam YH; Ghosh A; Tang MH; Tang LC; Lee CP; Sin SY; Ho PK Prenat Diagn; 1998 Jun; 18(6):585-89. PubMed ID: 9664604 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age. Hsu JJ; Hsieh TT; Soong YK; Spencer K Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893 [TBL] [Abstract][Full Text] [Related]
4. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy. Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131 [TBL] [Abstract][Full Text] [Related]
5. [Maternal serum AFP determination in the 2d trimester: a suitable screening method for detection of fetuses with Down's syndrome in young females?]. Mühlhaus K; Bock J Z Geburtshilfe Perinatol; 1990; 194(2):70-4. PubMed ID: 1693025 [TBL] [Abstract][Full Text] [Related]
6. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization. McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771 [TBL] [Abstract][Full Text] [Related]
7. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital. Lamlertkittikul S; Chandeying V J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410 [TBL] [Abstract][Full Text] [Related]
8. Age-independent indices in second-trimester serum screening for Down's syndrome are useless. Zimmermann R; Reynolds TM; John R; Spencer K; Bartels I; Coombes E; Trevor S Prenat Diagn; 1996 Jan; 16(1):79-82. PubMed ID: 8821858 [TBL] [Abstract][Full Text] [Related]
9. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases. Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230 [TBL] [Abstract][Full Text] [Related]
10. Maternal serum markers for Down's syndrome pregnancies. Chew S; Anandakumar C; Ratnam SS Singapore Med J; 1995 Aug; 36(4):417-23. PubMed ID: 8919160 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of triple test in second-trimester maternal serum screening for Down's syndrome: an experience from Taiwan with decreasing birth rate but increasing population of old pregnant women. Hwa HL; Yen MF; Lin CL; Ko TM; Hsieh FJ; Chen TH J Eval Clin Pract; 2008 Apr; 14(2):191-7. PubMed ID: 18284525 [TBL] [Abstract][Full Text] [Related]
12. [Screening by maternal serum markers for Down's syndrome]. Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710 [TBL] [Abstract][Full Text] [Related]
13. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers]. Arbuzova SB; Nikolenko MI; Khlevnaia LA; Fedotova OO; Solov'eva VD; Malova SA Tsitol Genet; 1998; 32(1):66-71. PubMed ID: 9695254 [TBL] [Abstract][Full Text] [Related]
14. [Maternal serum screening for Down syndrome and neural tube defects]. van Rijn M; Christiaens GC; van der Schouw YT; Hagenaars AM; de Pater JM; Visser GH Ned Tijdschr Geneeskd; 1998 Feb; 142(8):409-15. PubMed ID: 9562776 [TBL] [Abstract][Full Text] [Related]
15. The sensitivity of the trivariate analysis using maternal serum alpha-feto protein, human chorionic gonadotrophin and maternal age in screening for fetal aneuploidy in mothers above the age of 35. Anandakumar C; Chew S; Wong YC; Goh VH; Tain CF; Ratnam SS J Perinat Med; 1999; 27(3):178-82. PubMed ID: 10503178 [TBL] [Abstract][Full Text] [Related]
16. Estimating the risk of Down's syndrome in antenatal screening and the gestation at which this risk applies. Morris JK; Wald NJ J Med Screen; 2007; 14(1):5-7. PubMed ID: 17362564 [TBL] [Abstract][Full Text] [Related]
17. [Cost-benefit analysis of prenatal screening for trisomy 21 through analysis of HCG in maternal blood]. Seror V; Moatti JP; Muller F; Le Galès C; Boué A Rev Epidemiol Sante Publique; 1993; 41(1):3-15. PubMed ID: 8465062 [TBL] [Abstract][Full Text] [Related]
18. [Screening for Down's syndrome: results at the Klimentská Polyclinic Screening Center 1992-1994]. Stejskal D; Hlavová E; Cerný M; Polívková Z; Bíbrová J Ceska Gynekol; 1995 Feb; 60(1):17-21. PubMed ID: 7536599 [TBL] [Abstract][Full Text] [Related]
19. [Screening for Down syndrome using triple marker testing in the second trimester of pregnancy]. Lesin J; Skrablin S; Durić K; Suchanek E; Muzinić D; Kalafatić D; Kuvacić I; Zlopasa G; Plavec A Lijec Vjesn; 2003; 125(3-4):55-60. PubMed ID: 12899094 [TBL] [Abstract][Full Text] [Related]
20. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome]. Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]